Interventions and treatments for osteoporosis can prevent hip fractures, and bisphosphonates, such as alendronate and risedronate, or the neutralizing RANKL antibody denosumab reportedly block hip fractures relative to placebo controls45–47. This evidence concerns the gene TNFSF11 and osteoporosis.